Creating new chemical compounds using acetal radicals
Official title: Development of Acetal Radicals in Organic Synthesis
Funded at Temple Univ of the Commonwealth · NIH-10937382 · Data updated 2026-11-12
This study is exploring new ways to make important chemical compounds that could help create better medicines and agricultural products, using special techniques to ensure the process is safe and efficient.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Temple Univ of the Commonwealth NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | September 1, 2024 |
| Project end | June 30, 2029 |
| Funding year | 2024 |
| Award (this year) | $316,682 |
| NIH project number | 1R35GM154965-01 |
| Project ID | NIH-10937382 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include individuals with conditions that could be treated by new pharmaceutical agents derived from the synthesized compounds.
✕Less likely to help
Patients who are not affected by conditions treatable with the new compounds being developed may not receive any benefit from this research.
What this research studies
This research focuses on developing innovative chemical reagents and methods to create valuable carbonyl compounds from acetal-based radical precursors. By utilizing acetal radicals, the project aims to synthesize a variety of medicinally relevant molecules that can benefit the pharmaceutical and agrochemical industries. The research involves designing novel reagents to prevent unwanted side reactions and employing advanced techniques to construct complex molecular structures efficiently. This work is expected to enhance the capabilities of synthetic medicinal chemistry.
Why it matters
Potential benefit: If successful, this research could lead to the development of new drugs and therapeutic agents that improve patient outcomes.
How similar studies have gone: Other research in the field of organic synthesis has shown success in developing new reagents and methods, indicating that this approach has potential for significant advancements.
Where this research is happening
-
Temple Univ of the Commonwealth
Philadelphia, United States Active
Researchers
- Principal investigator: Kim, Daniel Kwanwoo — Temple Univ of the Commonwealth
- Study coordinator: Kim, Daniel Kwanwoo
Related research
Other NIH-funded projects on the same topics.
-
Complement in the heart’s microenvironment during renewal
This grant explores how immune signals involving the Complement system help heart cells multiply to repair the heart after a heart attack, with the goal of helping patients recover better.
-
Integrating clinical pharmacists into HIV care to reduce cardiovascular disease in people with HIV
A pharmacist-led program in HIV care aims to prevent and manage heart disease risks like high blood pressure, diabetes, and high cholesterol in people living with HIV.
-
NMDAR-TRPM4 signaling and mitochondria in Alzheimer's disease
Scientists are studying how a specific brain cell signaling pathway (NMDAR-TRPM4) relates to nerve cell damage and memory loss in Alzheimer's disease, using patient-derived stem cell models.
-
Understanding how human chaperone networks affect Alzheimer’s- and dementia-related proteins in yeast
Aims to map how human helper proteins (chaperones) interact with dementia-linked proteins using yeast to find which combinations could prevent harmful protein clumps.
-
CRISPR-based Cure for HIV: Targeting reservoirs and boosting immunity
Aims to use CRISPR gene editing to directly cut HIV provirus and strengthen immune responses so people living with HIV can better control the virus even after stopping therapy.
-
Steric-free labeling to map disease-related protein modifications
A scientist-led study uses advanced labeling tricks to identify disease-related protein modifications in human cells.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.